Vis enkel innførsel

dc.contributor.authorChaban, Viktoriia
dc.contributor.authorClarke, Gerard
dc.contributor.authorSkandsen, Toril
dc.contributor.authorIslam, Rakibul
dc.contributor.authorEinarsen, Cathrine Elisabeth
dc.contributor.authorVik, Anne
dc.contributor.authorDamås, Jan Kristian
dc.contributor.authorMollnes, Tom Eirik
dc.contributor.authorHåberg, Asta
dc.contributor.authorPischke, Soeren
dc.date.accessioned2021-04-27T11:45:23Z
dc.date.available2021-04-27T11:45:23Z
dc.date.issued2020-06-03
dc.description.abstractInnate immune activation has been attributed a key role in traumatic brain injury (TBI) and successive morbidity. In mild TBI (mTBI), however, the extent and persistence of innate immune activation are unknown. We determined plasma cytokine level changes over 12 months after an mTBI in hospitalized and non-hospitalized patients compared with community controls; and examined their associations to injury-related and demographic variables at admission. Prospectively, 207 patients presenting to the emergency department (ED) or general practitioner with clinically confirmed mTBI and 82 matched community controls were included. Plasma samples were obtained at admission, after 2 weeks, 3 months, and 12 months. Cytokine levels were analysed with a 27-plex beads-based immunoassay. Brain magnetic resonance imaging (MRI) was performed on all participants. Twelve cytokines were reliably detected. Plasma levels of interferon gamma (IFN-γ), interleukin 8 (IL-8), eotaxin, macrophage inflammatory protein-1-beta (MIP-1β), monocyte chemoattractant protein 1 (MCP-1), IL-17A, IL-9, tumor necrosis factor (TNF), and basic fibroblast growth factor (FGF-basic) were significantly increased at all time-points in patients compared with controls, whereas IFN-γ-inducing protein 10 (IP-10), platelet-derived growth factor (PDGF), and IL-1ra were not. IL-17A and FGF-basic showed significant increases in patients from admission to follow-up at 3 months, and remained increased at 12 months compared with admission. Interestingly, MRI findings were negatively associated with four cytokines: eotaxin, MIP-1β, IL-9, and IP-10, whereas age was positively associated with nine cytokines: IL-8, eotaxin, MIP-1β, MCP-1, IL-17A, IL-9, TNF, FGF-basic, and IL-1ra. TNF was also increased in those with presence of other injuries. In conclusion, mTBI activated the innate immune system consistently and this is the first study to show that several inflammatory cytokines remain increased for up to 1 year post-injury.en_US
dc.identifier.citationChaban, Clarke, Skandsen, Islam, Einarsen, Vik, Damås, Mollnes, Håberg, Pischke. Systemic inflammation persists the first year after mild traumatic brain injury: Results from the Prospective Trondheim Mild Traumatic Brain Injury Study. Journal of Neurotrauma. 2020;37(19):2120-2130en_US
dc.identifier.cristinIDFRIDAID 1886516
dc.identifier.doi10.1089/neu.2019.6963
dc.identifier.issn0897-7151
dc.identifier.issn1557-9042
dc.identifier.urihttps://hdl.handle.net/10037/21075
dc.language.isoengen_US
dc.publisherMary Ann Liebert, Inc.en_US
dc.relation.journalJournal of Neurotrauma
dc.relation.projectIDinfo:eu-repo/grantAgreement/RCN/SFF/223255/Norway/Centre of Molecular Inflammation Research/CEMIR/en_US
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2020 The Author(s)en_US
dc.subjectVDP::Medical disciplines: 700::Health sciences: 800::Epidemiology medical and dental statistics: 803en_US
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800::Epidemiologi medisinsk og odontologisk statistikk: 803en_US
dc.titleSystemic inflammation persists the first year after mild traumatic brain injury: Results from the Prospective Trondheim Mild Traumatic Brain Injury Studyen_US
dc.type.versionpublishedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel